J. Goldman & Co’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Buy |
+93,574
| New | +$1.62M | 0.04% | 217 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 214 |
|
|
2023
Q3 | – | Sell |
-8,476
| Closed | -$772K | – | 236 |
|
|
2023
Q2 | $772K | Sell |
8,476
-82,549
| -91% | -$7.52M | 0.03% | 171 |
|
|
2023
Q1 | $6M | Buy |
+91,025
| New | +$6M | 0.24% | 89 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 264 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 263 |
|
|
2022
Q2 | – | Sell |
-40,377
| Closed | -$2.05M | – | 234 |
|
|
2022
Q1 | $2.05M | Sell |
40,377
-7,636
| -16% | -$388K | 0.09% | 139 |
|
|
2021
Q4 | $2.27M | Buy |
+48,013
| New | +$2.27M | 0.13% | 135 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 307 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 322 |
|